Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Avricore Health ( (TSE:AVCR) ) is now available.
Avricore Health Inc. has announced the granting of stock options for 4,100,000 common shares to its directors, officers, employees, and consultants at an exercise price of CAD $0.05 per share. This move aligns with the company’s strategy to incentivize its team as it continues to expand its HealthTab™ platform, which provides point-of-care testing solutions and empowers pharmacists in primary care delivery, potentially enhancing its market position and offering new revenue streams.
Spark’s Take on TSE:AVCR Stock
According to Spark, TipRanks’ AI Analyst, TSE:AVCR is a Neutral.
Avricore Health’s strong financials and strategic corporate developments are offset by high valuation concerns and neutral technical indicators. The company’s financial stability and growth potential are promising, but profitability and valuation require attention.
To see Spark’s full report on TSE:AVCR stock, click here.
More about Avricore Health
Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies to advance pharmacy practice and patient care. Its flagship offering, HealthTab™, aims to create the world’s largest network of rapid testing devices in community pharmacies, making actionable health information more accessible.
YTD Price Performance: -8.33%
Average Trading Volume: 60,670
Technical Sentiment Signal: Sell
Current Market Cap: C$5.57M
For detailed information about AVCR stock, go to TipRanks’ Stock Analysis page.